Reuters logo
BRIEF-Botanix Pharmaceuticals announces completion of its pilot study of BTX 1701
June 7, 2017 / 11:55 PM / 4 months ago

BRIEF-Botanix Pharmaceuticals announces completion of its pilot study of BTX 1701

June 8 (Reuters) - Botanix Pharmaceuticals Ltd

* Announced completion of and initial human clinical data from its pilot study of BTX 1701 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below